Shreeve S M
Department of Pharmacology, Vermont Center for Vascular Research, University of Vermont, Burlington 05405.
Eur J Pharmacol. 1990 Jan 23;188(1):71-80. doi: 10.1016/0922-4106(90)90249-w.
[3H]Prazosin bound to a single class of high-affinity sites in both bovine aortic and rat hepatic membranes. The absolute affinity values of displacing ligands (prazosin greater than doxazosin much greater than trimazosin greater than yohimbine) were the same for both tissues. After solubilization of the alpha 1-adrenoceptors with digitonin and 3-[(3-cholamidopropyl)-dimethylammonio]-1-propane sulfonate, an identical rank order potency was observed. However, solubilization significantly reduced ligand affinity. In both tissues the affinity of prazosin was reduced 10- to 13-fold, whereas the affinities of doxazosin, trimazosin and yohimbine were reduced two- to six-fold. There appeared to be no relationship between the lipophilicities of the ligands and the degree to which affinity is affected by solubilization. The results suggest that the reductions in affinity are the consequence of a conformational change in the alpha 1-adrenoceptor and appear to support the hypothesis that the alpha 1-adrenoceptor is so constructed that the spatial configuration of the binding site can change in response to an alteration in its microenvironment.
[3H]哌唑嗪与牛主动脉和大鼠肝细胞膜中的一类高亲和力位点结合。两种组织中置换配体的绝对亲和力值(哌唑嗪>多沙唑嗪>曲马唑嗪>育亨宾)相同。用洋地黄皂苷和3-[(3-胆酰胺丙基)-二甲基铵]-1-丙烷磺酸盐溶解α1-肾上腺素能受体后,观察到相同的效价顺序。然而,溶解显著降低了配体亲和力。在两种组织中,哌唑嗪的亲和力降低了10至13倍,而多沙唑嗪、曲马唑嗪和育亨宾的亲和力降低了2至6倍。配体的亲脂性与亲和力受溶解影响的程度之间似乎没有关系。结果表明,亲和力的降低是α1-肾上腺素能受体构象变化的结果,似乎支持了这样的假设,即α1-肾上腺素能受体的结构使得结合位点的空间构型能够响应其微环境的改变而变化。